Q4 2023 13F Holders as of 31 Dec 2023
-
Type / Class
-
Equity / Ordinary Shares, no par value
-
Shares outstanding
-
86,723,804
-
Total 13F shares
-
1,840,525
-
Share change
-
+851,721
-
Total reported value
-
$5,505,585
-
Price per share
-
$3.01
-
Number of holders
-
26
-
Value change
-
+$2,478,553
-
Number of buys
-
11
-
Number of sells
-
6
Institutional Holders of Alpha Tau Medical Ltd. - Ordinary Shares, no par value (DRTS) as of Q4 2023
As of 31 Dec 2023 Alpha Tau Medical Ltd. - Ordinary Shares, no par value (DRTS) had 26 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 1,840,525 shares of stock of the company.
Largest 10 holders included LEVIN CAPITAL STRATEGIES, L.P., MORGAN STANLEY, HoyleCohen, LLC, Corbin Capital Partners, L.P., HighTower Advisors, LLC, Atalaya Capital Management LP, Private Advisor Group, LLC, SATOVSKY ASSET MANAGEMENT LLC, Mariner, LLC, and GEODE CAPITAL MANAGEMENT, LLC.
This table shows 26 institutional shareholders of the security as of 31 Dec 2023.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.